Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors

od Baram, Tamir, Erlichman, Nofar, Dadiani, Maya, Balint-Lahat, Nora, Pavlovski, Anya, Meshel, Tsipi, Morzaev-Sulzbach, Dana, Gal-Yam, Einav Nili, Barshack, Iris, Ben-Baruch, Adit
Wydane w Cells (2021)

mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues

od Bossel Ben-Moshe, Noa, Gilad, Shlomit, Perry, Gili, Benjamin, Sima, Balint-Lahat, Nora, Pavlovsky, Anya, Halperin, Sharon, Markus, Barak, Yosepovich, Ady, Barshack, Iris, Gal-Yam, Einav Nili, Domany, Eytan, Kaufman, Bella, Dadiani, Maya
Wydane w BMC Genomics (2018)

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

od Zundelevich, Adi, Dadiani, Maya, Kahana-Edwin, Smadar, Itay, Amit, Sella, Tal, Gadot, Moran, Cesarkas, Karen, Farage-Barhom, Sarit, Saar, Efrat Glick, Eyal, Eran, Kol, Nitzan, Pavlovski, Anya, Balint-Lahat, Nora, Dick-Necula, Daniela, Barshack, Iris, Kaufman, Bella, Gal-Yam, Einav Nili
Wydane w Breast Cancer Res (2020)

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

od Zundelevich, Adi, Dadiani, Maya, Kahana-Edwin, Smadar, Itay, Amit, Sella, Tal, Gadot, Moran, Cesarkas, Karen, Farage-Barhom, Sarit, Saar, Efrat Glick, Eyal, Eran, Kol, Nitzan, Pavlovski, Anya, Balint-Lahat, Nora, Dick-Necula, Daniela, Barshack, Iris, Kaufman, Bella, Gal-Yam, Einav Nili
Wydane w Breast Cancer Res (2020)

Automated thermal imaging for the detection of fatty liver disease

od Brzezinski, Rafael Y., Levin-Kotler, Lapaz, Rabin, Neta, Ovadia-Blechman, Zehava, Zimmer, Yair, Sternfeld, Adi, Finchelman, Joanna Molad, Unis, Razan, Lewis, Nir, Tepper-Shaihov, Olga, Naftali-Shani, Nili, Balint-Lahat, Nora, Safran, Michal, Ben-Ari, Ziv, Grossman, Ehud, Leor, Jonathan, Hoffer, Oshrit
Wydane w Sci Rep (2020)

Cancer-associated fibroblast compositions change with breast-cancer progression linking the ratio of S100A4(+) and PDPN(+) CAFs to clinical outcome

od Friedman, Gil, Levi-Galibov, Oshrat, David, Eyal, Bornstein, Chamutal, Giladi, Amir, Dadiani, Maya, Mayo, Avi, Halperin, Coral, Pevsner-Fischer, Meirav, Lavon, Hagar, Mayer, Shimrit, Nevo, Reinat, Stein, Yaniv, Balint-Lahat, Nora, Barshack, Iris, Ali, H. Raza, Caldas, Carlos, Nili-Gal-Yam, Einav, Alon, Uri, Amit, Ido, Scherz-Shouval, Ruth
Wydane w Nat Cancer (2020)